<?xml version="1.0" encoding="UTF-8"?>
<billStatus>
  <bill>
    <policyArea>
      <name>Health</name>
    </policyArea>
    <constitutionalAuthorityStatementText><![CDATA[<pre>From the Congressional Record Online through the Government Publishing Office [<a href='http://www.gpo.gov'>www.gpo.gov</a>]By Mr. PITTS:H.R. 2455.Congress has the power to enact this legislation pursuantto the following:Article I, Section 8, Clause 1[Page H3390]</pre>]]></constitutionalAuthorityStatementText>
    <sponsors>
      <item>
        <identifiers>
          <bioguideId>P000373</bioguideId>
          <gpoId>8134</gpoId>
          <lisID>1514</lisID>
        </identifiers>
        <district>16</district>
        <byRequestType />
        <fullName>Rep. Pitts, Joseph R. [R-PA-16]</fullName>
        <firstName>JOSEPH</firstName>
        <state>PA</state>
        <bioguideId>P000373</bioguideId>
        <middleName>R.</middleName>
        <party>R</party>
        <lastName>PITTS</lastName>
      </item>
    </sponsors>
    <committeeReports />
    <titles>
      <item>
        <parentTitleType />
        <titleType>Official Title as Introduced</titleType>
        <title>To amend the Federal Food, Drug, and Cosmetic Act with respect to precision medicine.</title>
        <chamberCode />
        <chamberName />
      </item>
      <item>
        <parentTitleType />
        <titleType>Display Title</titleType>
        <title>To amend the Federal Food, Drug, and Cosmetic Act with respect to precision medicine.</title>
        <chamberCode />
        <chamberName />
      </item>
    </titles>
    <laws />
    <createDate>2015-05-20T08:46:22Z</createDate>
    <recordedVotes />
    <billNumber>2455</billNumber>
    <originChamber>House</originChamber>
    <committees>
      <billCommittees>
        <item>
          <subcommittees>
            <item>
              <systemCode>hsif14</systemCode>
              <activities>
                <item>
                  <date>2015-05-22T15:12:49Z</date>
                  <name>Referred to</name>
                </item>
              </activities>
              <name>Health Subcommittee</name>
            </item>
          </subcommittees>
          <chamber>House</chamber>
          <systemCode>hsif00</systemCode>
          <activities>
            <item>
              <date>2015-05-19T14:07:00Z</date>
              <name>Referred to</name>
            </item>
          </activities>
          <type>Standing</type>
          <name>Energy and Commerce Committee</name>
        </item>
      </billCommittees>
    </committees>
    <relatedBills>
      <item>
        <congress>114</congress>
        <type>HR</type>
        <relationshipDetails>
          <item>
            <identifiedBy>CRS</identifiedBy>
            <type>Related bill</type>
          </item>
        </relationshipDetails>
        <number>6</number>
        <latestAction>
          <actionDate>2015-07-13</actionDate>
          <text>Received in the Senate and Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text>
        </latestAction>
        <latestTitle>21st Century Cures Act</latestTitle>
      </item>
    </relatedBills>
    <updateDate>2016-11-02T22:08:10Z</updateDate>
    <summaries>
      <billSummaries>
        <item>
          <versionCode>00</versionCode>
          <actionDate>2015-05-19</actionDate>
          <text><![CDATA[<p>This bill amends the Federal Food, Drug, and Cosmetic Act to require the Food and Drug Administration (FDA) to define &quot;precision drug or biological product.&quot; (Precision medications are commonly understood to be treatments for those patients who are likely to respond to the medication based on a biomarker, which is a biological characteristic such as a genetic factor.)</p> <p>The FDA must issue and periodically update guidance that addresses the development and use of biomarkers to identify the subset of patients that are likely to respond to a medication. </p> The FDA may rely upon data previously submitted for a different approved medication or indication to expedite the clinical development of a precision medication that has been designated for the treatment of a serious or rare condition.]]></text>
          <lastSummaryUpdateDate>2015-11-17T12:45:24Z</lastSummaryUpdateDate>
          <actionDesc>Introduced in House</actionDesc>
          <name>Introduced in House</name>
          <updateDate>2015-05-19T04:00:00Z</updateDate>
        </item>
      </billSummaries>
    </summaries>
    <congress>114</congress>
    <title>To amend the Federal Food, Drug, and Cosmetic Act with respect to precision medicine.</title>
    <calendarNumbers />
    <actions>
      <actionTypeCounts>
        <placeholderTextForH>1</placeholderTextForH>
        <billReferrals>1</billReferrals>
        <introducedInTheHouse>1</introducedInTheHouse>
        <introducedInHouse>1</introducedInHouse>
      </actionTypeCounts>
      <item>
        <actionDate>2015-05-22</actionDate>
        <committee>
          <name>Health Subcommittee</name>
          <systemCode>hsif14</systemCode>
        </committee>
        <links />
        <sourceSystem>
          <code>1</code>
          <name>House committee actions</name>
        </sourceSystem>
        <text>Referred to the Subcommittee on Health.</text>
        <type>Committee</type>
      </item>
      <item>
        <actionDate>2015-05-19</actionDate>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
        <text>Referred to the House Committee on Energy and Commerce.</text>
        <type>IntroReferral</type>
        <links />
        <actionCode>H11100</actionCode>
        <committee>
          <name>Energy and Commerce Committee</name>
          <systemCode>hsif00</systemCode>
        </committee>
      </item>
      <item>
        <actionDate>2015-05-19</actionDate>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
        <text>Introduced in House</text>
        <type>IntroReferral</type>
        <links />
        <actionCode>Intro-H</actionCode>
        <committee />
      </item>
      <item>
        <actionDate>2015-05-19</actionDate>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
        <text>Introduced in House</text>
        <type>IntroReferral</type>
        <links />
        <actionCode>1000</actionCode>
        <committee />
      </item>
      <actionByCounts>
        <houseOfRepresentatives>4</houseOfRepresentatives>
      </actionByCounts>
    </actions>
    <amendments />
    <cboCostEstimates />
    <introducedDate>2015-05-19</introducedDate>
    <latestAction>
      <text>Referred to the Subcommittee on Health.</text>
      <actionDate>2015-05-22</actionDate>
      <links />
    </latestAction>
    <subjects>
      <billSubjects>
        <legislativeSubjects>
          <item>
            <name>Administrative law and regulatory procedures</name>
          </item>
          <item>
            <name>Department of Health and Human Services</name>
          </item>
          <item>
            <name>Drug safety, medical device, and laboratory regulation</name>
          </item>
          <item>
            <name>Prescription drugs</name>
          </item>
        </legislativeSubjects>
        <policyArea>
          <name>Health</name>
        </policyArea>
      </billSubjects>
    </subjects>
    <cosponsors />
    <notes />
    <billType>HR</billType>
  </bill>
  <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
    <dc:format>text/xml</dc:format>
    <dc:language>EN</dc:language>
    <dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
    <dc:contributor>Congressional Research Service, Library of Congress</dc:contributor>
    <dc:description>This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.</dc:description>
  </dublinCore>
</billStatus>

